These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 286667)

  • 1. Overshoot phenomenon of phytohemagglutinin response after chemotherapy and its relationship to remission in acute non-lymphocytic leukemia.
    Harada M; Mori T; Kodo H; Ishino C; Matsue K; Hattori K
    Gan; 1979 Feb; 70(1):89-93. PubMed ID: 286667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity skin reactions in the induction phase of remission in acute non lymphoid leukemias.
    Vu Van H; Fiere D; Doillon M; Martin C; Coiffier B; Revol L
    Biomedicine; 1978; 28(3):166-9. PubMed ID: 279357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in acute nonlymphocytic leukemia: relationship to host factors, therapy, and prognosis.
    Greene WH; Schimpff SC; Wiernik PH
    Blood; 1974 Jan; 43(1):1-14. PubMed ID: 4520148
    [No Abstract]   [Full Text] [Related]  

  • 5. Rebound phenomenon of phytohemagglutinin skin reactivity in leukemia and malignant lymphoma after chemotherapy.
    Sone S; Yata K; Tsubura E
    Gan; 1977 Aug; 68(4):483-90. PubMed ID: 616418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
    Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
    J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
    del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
    Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune status in children with acute lymphocytic leukemia. Observations in 67 cases.
    Bardare M; Pietrogrande MC; Corona F; Varin E; Carnelli V; Masera G
    Helv Paediatr Acta; 1978 Aug; 33(3):241-50. PubMed ID: 309463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute leukemia. Case material and therapeutic results].
    Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
    Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daunorubicin-prednisone remission induction with hydroxyurea maintenance in acute non-lymphocytic leukemia.
    Bloomfield CD; Brunning RD; Theologides A; Kennedy BJ
    Cancer; 1973 Apr; 31(4):931-8. PubMed ID: 4513295
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment of acute luekemia in adults according to our records].
    Kotlarek-Haus S; Witkowska M; Kuliszkiewicz M
    Acta Haematol Pol; 1975; 6(1):51-8. PubMed ID: 1054903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed lymphocyte-tumor cell reaction between remission lymphocytes and autochthonous leukemia cells and its relationship to the prognosis of acute leukemia.
    Ohno R; Ezaki K; Kodera Y; Tanimoto M; Yamada K
    Gan; 1980 Aug; 71(4):451-6. PubMed ID: 6448761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
    Larson RA; Lukin CL; Daly KM; Mick R; Gore S; Le Beau MM
    Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia.
    Takahashi I; Yorimitsu S; Hara M; Inagaki T; Nakada H; Sekito N; Hayashi N; Nonaka K; Ohmoto E; Uchida K
    Acta Med Okayama; 1986 Jun; 40(3):175-7. PubMed ID: 3461685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of cellular immunity to prognosis in acute leukemia.
    Toki H; Takahashi Y; Nakanishi N; Naito T; Chen P; Takahashi I; Kitajima K
    Acta Med Okayama; 1977 Feb; 31(1):51-8. PubMed ID: 140590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
    Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
    Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).
    Wiernik PH; Serpick AA
    Medicine (Baltimore); 1970 Nov; 49(6):505-13. PubMed ID: 5286084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.